Dr. Ashish Kumar Vyas

Assistant Professor, Group Leader Immunology & DST Inspire Faculty | Viral Immunology | Viral Hepatitis | Infectious Diseases | Liver Diseases

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

HIV-HBV Co-infections in Central India: Prevalence, Clearance Rates, and Long-term Outcomes from a Decade of Experience at a Tertiary Care Center. https://t.co/tfwLYS9lrJ @rawat5000 @HIVGov

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

I’ve just joined @NO_hep, the global movement to eliminate viral #hepatitis by 2030. Find out more and join me to change the lives of millions of people around the world: https://t.co/0WBYe0yPDd #NOhep

[Ajay Duseja @ajay_duseja]

Asian Pacific Digestive Week - 2022
Enjoyed the morning session on NAFLD
- Epidemiology
- Risk Stratification
- Lifestyle Interventions
Thanks #APDW

[Ajay Duseja @ajay_duseja]

INASL Announces it's Annual Meeting
3-6th August, 2023
Mayfair Convention and Lagoon
Bhubaneswar, India
BLOCK YOUR DATES

[Anand V Kulkarni @AnandVKulkarni2]

Great presentation by @docMPK

Intriguing questions by @pummy92 @singal_ashwani Prof. Wong and Prof. Gines. @AtoosaRabiee @NancyReau #livertwitter #TLM22 @AASLDtweets #terlipressin @US_FDA

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

Congratulations @AnandVKulkarni2

[AASLD Foundation @AASLDFoundation]

Huge Congratulations to all our awardees! The future of #hepatology is in good hands. #TLM22

[Anand V Kulkarni @AnandVKulkarni2]

Now online ⁦@ImmunologyNews #vaccinejournal⁩
✅Lower CD4 effector cells and B cells among decomp cirrhosis & tx recipients
✅Higher non response to Covishield/ covaxin among DC & tx recipients.
⁦@INASL_Liver⁩ ⁦@_LTSI_⁩ ⁦#liver twitter https://t.co/n7Xs3MIxjS

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

#UEGWeek

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

@Pratibha28Garg @INASL_Liver @nipun29j Hey I left early on 2nd day of conference. One my friend informed me that I got 2nd prize in poster. Can you help me how I will get that and whine to contact for the same. My no is 9540946986.

[Anand V Kulkarni @AnandVKulkarni2]

Honoured to meet the coolest hepatologist of India ⁦@DrKaushalMadan1⁩

With Dr Ashish Vyas (the HBV scientist)
#livertwitter

[Chokshi Lab London @ChokshiLab]

Many congratulations 👏 👏👏

[Anand V Kulkarni @AnandVKulkarni2]

Must read article now ⁦@JHepatology⁩ -Expert opinion for nomenclature Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators
by ⁦@ThomasBerg24⁩ Prof. Ana Lok Prof. Raj Reddy #livertwitter https://t.co/Sozt8M0TjQ

[Hepatoma Research @HepatomaRes]

#CD8Tcells #hcc #meded #LiverTwitte👏Welcome to read and download this excellent article "#CytotoxicImmune cell-based #immunotherapy for hepatocellular carcinoma" by Dr. Xuefu Wang's team.
🔗https://t.co/QZzLsBvqzf
📕https://t.co/ctxxfluKsS
@ShimaghavimiMD @vij_mukul @LouisHSLau

[Brijendra Pratap Singh @Bpsingh_bjp]

धार जिले के खलघाट में यात्री बस के नर्मदा नदी में गिरने से कई लोगों के असामयिक निधन का दुःखद समाचार प्राप्त हुआ।

भगवान जुगल कि��ोर जी से प्रार्थना है कि वे दिवंगतों की आत्मा को शांति दें और परिजनों को यह दुःख सहन करने की शक्ति व घायलों को शीघ्र स्वास्थ्य लाभ प्रदान करें।

[Chokshi Lab London @ChokshiLab]

I am pleased to announce that our review on #NovelTherapeutics for #Chronic #HepatitisB is out now. You can learn about this engaging topic here:

https://t.co/SXJ128QKT4

#HepB #HBV #LiverTwitter @SandraP97_1 @DrAntonioRiva @DrElePalma @_R4V1 @tandfonline @EASLedu @EASLnews

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

Participating in the panel discussion on the global movement to eliminate viral hepatitis by 2030 NOhep,#WHO, and one of the panel members on the prevention of mother-to-child transmission of hepatitis (PMTCT). .#worldhepatitisalliance, # Geneva, Switzerland.

[Anand V Kulkarni @AnandVKulkarni2]

Fight the disease, not the nomenclature! #NAFLDvsMAFLD . #livertwitter @rabataller @shivaramsingh @ajay_duseja @AtoosaRabiee @ChengHanNg @DrLoomba @NASH_and_coffee

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

Participating and presenting our Immunology research in #ImmunoconBHU for prestigious Dr. GP Talwar young scientist award. Thank you Indian Immunology Society for the great opportunity #research #immunology #Indianimmunology

[Anand V Kulkarni @AnandVKulkarni2]

Meeting friends across globe! @savykaur3 @AshishKumarVya1 @juanpabloarab @LuisAntonioDiaz

Thank you for the great start!
@EASLnews @EASLedu @ThomasBerg24 @AleksanderKrag #ILC2022 #LiverTwitter

[Dr. Ashish Kumar Vyas @AshishKumarVya1]

Going to participate and present our research in Young Investigator awardee session among top 100 categories, In one of the largest liver conference of the world, The International Liver Congress, London,
Many Congratulations to all the authors. 🇮🇳#DST, #DSTInspire, #AIIMSBhopal